Vimarsana.com

Latest Breaking News On - Apyx medical corporation call - Page 1 : vimarsana.com

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mike-piccinino
Apyx-medical-corporation-call
Apyx-medical-corporation
Helium-plasma-technology
Medical-corporation
Investor-relations
Apyx-medical-earnings
Apyx-medical

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Apyx® Medical Corporation , the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the third...

Apyx-medical-corporation
Helium-plasma-technology
Apyx-medical-corporation-call
Medical-corporation
Investor-relations
Markets

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the second quarter of fi...

Helium-plasma-technology
Apyx-medical-corporation-call
Apyx-medical-corporation
Medical-corporation
Investor-relations
Markets

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mike-piccinino
Apyx-medical-corporation
Helium-plasma-technology
Apyx-medical-corporation-call
Medical-corporation
Investor-relations
Apyx-medical

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial...

Company-helium-plasma-technology
Apyx-medical-corporation
Helium-plasma-technology
Apyx-medical-corporation-call
Investor-relations
Medical-corporation

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 1

Search jobs 12-Jul-2021 Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021 CLEARWATER, Fla.--(BUSINESS WIRE)-- Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the second quarter of fiscal year 2021 will be released before the market opens on Thursday, August 12th. Management will host a conference call at 8:00 a.m. Eastern Time on August 12th to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 877-407-8289 (or 201-689-8341 for international callers) and provide access code 13721407. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company’s website and at:

Apyx-medical-corporation
Helium-plasma-technology
Apyx-medical-corporation-call
Investor-relations
Medical-corporation
கதிர்வளி-பிளாஸ்மா-தொழில்நுட்பம்
முதலீட்டாளர்-உறவுகள்
மருத்துவ-நிறுவனம்

vimarsana © 2020. All Rights Reserved.